Terminal care and pain management.
The pain experienced by terminal patients is not just physical; it is often accompanied by emotional stress and anxiety. Conventional painkillers are frequently insufficient for managing this multidimensional pain, and their continued use can lead to side effects such as loss of appetite, constipation, and mental confusion. THC, the active compound in cannabis, not only suppresses pain transmission but also affects the brain’s reward system, potentially altering the way patients respond to pain.
Cannabinoids have proven effective in managing chronic pain. Studies have shown that cannabinoids provide pain relief comparable to opioid medications, with fewer side effects, allowing for a reduction in opioid use. Moreover, cannabis plays a significant role in maintaining mental health. Anxiety and depression are common among terminal patients, and cannabis, particularly CBD, has shown a positive impact on mental well-being. CBD interacts with serotonin receptors, helping to reduce stress, and has been shown to alleviate anxiety, thereby improving patients’ quality of life. In fact, cases have reported significant reductions in anxiety levels among terminal cancer patients after receiving CBD treatment. This emotional stability also contributes to better pain management and appetite improvement, enhancing overall patient well-being.
In terms of appetite, terminal patients often experience severe loss of appetite due to cancer progression or chemotherapy, leading to malnutrition, fatigue, and weakened immune systems. THC stimulates appetite by acting on the brain’s appetite control centers, helping to combat this decline.
Some patients using cannabis containing THC have reported improvements in appetite, weight gain, and increased food intake. Chemotherapy-induced nausea and vomiting are particularly distressing experiences for patients, and cannabis has proven to be an effective remedy for alleviating these symptoms, with THC being the primary active component. THC works by acting on the brain’s vomiting center, helping to suppress nausea. Additionally, research into various cannabinoids, such as CBN, and terpenes is ongoing. By continuing cannabis-based treatments, patients often experience an improved quality of life. With changes in legal frameworks worldwide, ongoing research and clinical trials on medical cannabis offer the hope that more patients will be able to benefit from this treatment in the future.
Research on the medical use of cannabis has been increasing, and substantial evidence has been accumulating regarding its efficacy. However, it has not yet been fully established in all fields, and further studies are needed to assess its long-term safety and effectiveness. While many patients have reported that ‘pain was relieved, and I was able to enjoy meals,’ the evidence is not yet definitive due to limitations such as the number of case studies and academic papers. Still, in medical settings, there is growing hope for treatments tailored to patient needs, especially in palliative care.
The use of cannabis in end-of-life care holds great potential for pain management, improving mental health, increasing appetite, and alleviating nausea. However, its use is accompanied by legal restrictions and societal stigma, requiring careful judgment and appropriate guidance from medical professionals. As legal frameworks evolve and research advances, it is anticipated that more patients will benefit from this treatment. To demonstrate the meaningful impact of cannabis on terminally ill patients, further exploration in medicine, pharmacology, and science is essential. For those in need, the urgency for access is immediate, with no time to wait.